NRBO NeuroBo Pharma Operating Profitability

NRBO (NeuroBo Pharmaceuticals) - company brandmark

NeuroBo Pharmaceuticals generates revenue through partnerships in the development of drugs for liver pathologies, obesity, and neurodegeneration. The adjusted operating margin allows for an assessment of these processes' dynamics, while 0.00 indicates the current level. Innovative molecules for the therapy of metabolic disorders with long-term patent protection establish the foundation for future revenues. Currently, NeuroBo Pharmaceuticals is focused on clinical trials of cardiometabolic drugs without the presence of stable cash flows.

neurobopharma.com (NRBO): Operating Sales Margin from 07/04/2022 to 12/07/2024

Analytical breakdowns for NeuroBo Pharmaceuticals

- share price and consensus valuation forecast:
Fundamental company analysis:NeuroBo Pharmaceuticals Inc
Finished products of NeuroBo Pharma

The NeuroBo Pharmaceuticals (NRBO) business model focuses on the commercialization of metabolic disorder therapies, with primary expenditures directed toward the development of obesity and MASH drugs. An analysis of the operating profit margin allows for an assessment of expense management efficiency before taxes and interest, while the low values on this chart for small-cap companies often reflect a phase of aggressive R&D investment.

Main competitors

Operating Sales Margin BIIB|NBIX: Operating Profit Rate|Operating Profitability Regencell Bioscience Ltd (RGC)|Operating Margin axsome.com (AXSM)|Operating Margin ACAD (acadia-pharm.com)|XENE - Operating Sales Margin|vikingtherapeutics.com - Operating Margin|Supernus Pharma (SUPN) - Operating Sales Margin|CPRX: Operating Margin|Denali Therapeutics Inc. (DNLI) - Operating Margin|Operating Profitability Harmony Pharma|Operating Profitability BHVN|Operating Sales Margin AMLX (Amylyx Pharmaceuticals, Inc.)|Operating Sales Margin Trevi Corp TRVI|Operating Profitability praxismedicines.com PRAX|AVXL - Operating Sales Margin|CeriBell EEG - Operating Margin|Operating Return on Sales prothena.com|Alector Therapeutics (ALEC) - Operating Profitability|Annexon Biosciences Inc. - Operating Profit Rate|OMER (Omeros Corp) - Operating Margin|Operating Margin neurogene.com|Operating Margin ACIU|VYGR - Operating Return on Sales|Operating Profitability Neumora Therapeutics Inc NMRA|Profitability of Operations Scilex Holding Co. (SCLX)|TVGN - Operating Profitability|Operating Return on Sales alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Operating Sales Margin|IKT: Operating Profit Ratio|Operating Profitability Cassava Sciences, Inc.|ASRT (assertiotx.com) - Operating Profit Ratio|Operating Profitability Coya (COYA)|VTGN - Operating Return on Sales|Operating Margin OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Operating Return on Sales|cervomed.com - Operating Margin|Operating Profit Rate ATHE (Alterity Therapeutics Limited)|CLNN: Operating Margin|Operating Sales Margin PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Operating Margin|Operating Return on Sales Relmada Therapeutics Inc RLMD|Operating Profitability Annovis Bio Corporation (ANVS)|GRCE - Operating Return on Sales|Operating Profitability Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Operating Return on Sales|NeuroSense Therapeutics, Ltd. - Operating Margin|RVPH: Operating Profitability|MTVA: Operating Margin|NRXS - Profitability of Operations|HSDT (Helius Medical Technologies Inc.) - Operating Margin|Operating Return on Sales Passage Bio PASG|Operating Profitability Neuphoria (NEUP)|Operating Margin Minerva Neurosciences Corp (NERV)|Operating Profitability Athira ATHA|Operating Margin Addex ADXN|Alzamend - Operating Margin|Operating Return on Sales Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Operating Profitability|KTTA: Operating Profit Ratio|Operating Sales Margin CRGT|Avenue Therapeutics, Inc - Operating Profit Margin|Operating Profitability Brainstorm Cell (BCLI)|CARA: Operating Profit Margin|Chromocell Therapeutics Corp. - Operating Sales Margin|Profitability of Operations Eliem (ELYM)|ITCI: Operating Sales Margin|Operating Profit Rate LBPH (Longboard)|marinuspharma.com (MRNS) - Operating Profitability|NKGN - Profitability of Operations|SAGE (Sage Therapeutics Inc.) - Operating Margin|Neurotrope - Operating Profit Margin|Operating Margin TRVN|Profitability of Operations Vigil Neuroscience, Inc.|Operating Profitability Anew Medical, Inc. WENA|CERE - Operating Sales Margin